Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 5,779 | 4,592 | 4,621 | 266 | 3,826 |
| Operating Income | -5,779 | -4,592 | -4,621 | -266 | -3,826 |
| Other Income | -1 | 47 | 95 | 1,082 | 77 |
| Pre-tax Income | -5,780 | -4,545 | -4,525 | 816 | -3,749 |
| Net Income Continuous | -5,780 | -4,545 | -4,525 | 816 | -3,749 |
| Net Income | $-5,780 | $-4,545 | $-4,525 | $816 | $-3,749 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.02 | N/A | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | 0.01 | -0.02 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.02 | N/A | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | 0.01 | -0.02 |
| EBITDA(a) | $-5,608 | $-4,421 | $-4,450 | $-95 | $-3,656 |